Last $41.38 USD
Change Today +0.25 / 0.61%
Volume 588.0K
A On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

agilent technologies inc (A) Key Developments

Agilent Technologies Inc.(NYSE:A) dropped from S&P 500 Growth Index

Agilent Technologies Inc.(NYSE:A) dropped from S&P 500 Growth Index

Agilent Technologies and Baylor College of Medicine Open Center of Excellence in Mass Spectrometry

Agilent Technologies Inc. and Baylor College of Medicine, both known for their expertise in metabolomics, are working together to advance research and training in this vital branch of the life sciences. To that end, Agilent and Baylor have opened the Agilent Technologies Mass Spectrometry Center of Excellence as part of the Alkek Center for Molecular Discovery and the Baylor College of Medicine Core Laboratory in the college's department of molecular and cellular biology. Agilent is equipping the new center with two systems configured for metabolomics: an Agilent 6495 triple quadrupole LC/MS system and an Agilent 6550 iFunnel quadrupole time-of-flight LC/MS system with a switchable GC APCI interface. The systems include Mass Hunter software for qualitative and quantitative analysis as well as Mass Profiler Professional with Pathway Architect for bioinformatics and integrated multi-omic analysis. Baylor and Agilent will use the equipment collaboratively to analyze samples, conduct research and train students. Both parties have enjoyed a long-standing scientific relationship, which has resulted in several published application breakthroughs in cancer metabolomics.

Agilent Technologies Inc. Announces Quarterly Cash Dividend, Payable on Jan. 28, 2015

Agilent Technologies Inc. announced that a quarterly dividend of 10 cents per share of common stock will be paid on Jan. 28, 2015, to all shareholders of record as of the close of business on Jan. 6, 2015.

Agilent Technologies Inc. Announces Executive Changes

Agilent Technologies Inc. announced that it has named two new business presidents and realigned its businesses to better serve customers. Patrick Kaltenbach has been named senior vice president, Agilent, and president of the Life Sciences and Applied Markets Group (LSAG) business unit, which combines the former Chemical Analysis Group and Life Sciences business. Jacob Thaysen has been appointed senior vice president, Agilent, and president of the Diagnostics and Genomics Group (DGG). This new business unit combines the Diagnostics and Genomics businesses and will serve the needs of clinical laboratories. Both appointments are effective immediately. Fred Strohmeier, who has been president of the Life Sciences and Diagnostics Group (LDG), has announced his retirement, planned for the second quarter of fiscal year 2015. He will serve as an advisor to the company until that time. As group president for LSAG, Kaltenbach is responsible for leading Agilent's life sciences and applied chemical markets business. Kaltenbach was most recently Agilent vice president and general manager of the Life Sciences Products and Solutions organization, where he had responsibility for the strategic direction and development of all Agilent life science products. As group president of DGG, Thaysen is now responsible for the strategic direction and day-to-day management of Agilent's diagnostics and genomics business. Thaysen was most recently vice president and general manager of Agilent's Diagnostics and Genomics business within LDG. He was responsible for its overall operation, including strategic direction, project management, sales, marketing and R&D.

Agilent Technologies Inc. Reports Preliminary Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended October 31, 2014; Provides Earnings Guidance for the First Quarter and Full Fiscal Year of 2015

Agilent Technologies Inc. reported preliminary unaudited consolidated earnings results for the fourth quarter and full year ended October 31, 2014. For the quarter, the company reported net revenues of $1,805 million against $1,718 million a year ago. Income from operations was $174 million against $285 million last year. Income before taxes was $85 million against $254 million last year. Net income was $16 million or $0.05 per diluted share against $211 million or $0.63 per diluted share last year. Net cash provided by operating activities was $166 million. Investments in property, plant and equipment was $45 million. Non-GAAP net income was $297 million or $0.88 per diluted share against $271 million or $0.81 per diluted share last year. For the year, the company reported net revenues of $6,981 million against $6,782 million last year. Income from operations was $831 million against $951 million last year. Income before taxes was $646 million against $859 million last year. Net income was $497 million or $1.47 per diluted share against $724 million or $2.10 per diluted share last year. Non-GAAP net income was $1,029 million or $3.04 per diluted share against $995 million or $2.88 per diluted share last year. Net cash provided by operating activities was $713 million. Investments in property, plant and equipment was $207 million. For the first quarter of 2015, the company revenues are expected to be in the range of $1.02 billion to $1.04 billion. First-quarter non-GAAP earnings are expected to be in the range of $0.39 to $0.43 per share. For the full fiscal year 2015, the company expects revenue of $4.12 billion to $4.18 billion and non-GAAP earnings of $1.68 to $1.78 per share. Non-GAAP effective tax rate is projected to be 20%. Operating cash flow expects to be in between $600 million. capital expenditures expects to be in between $120 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
A:US $41.38 USD +0.25

A Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AMETEK Inc $53.98 USD 0.00
KLA-Tencor Corp $71.85 USD -0.17
NVIDIA Corp $20.59 USD +0.02
Sigma-Aldrich Corp $137.21 USD +0.05
Xilinx Inc $43.92 USD -0.165
View Industry Companies
 

Industry Analysis

A

Industry Average

Valuation A Industry Range
Price/Earnings 27.8x
Price/Sales 2.0x
Price/Book 2.6x
Price/Cash Flow 27.5x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AGILENT TECHNOLOGIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.